Martin Vojtek
Porto, 4050313, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Phosphodiesterase 3 inhibition mitigates sepsis progression in a rodent sepsis model.
Journal: Life sciences
Published: August 06, 2025
Trihydroxylated Anthocyanins Potentiate Effects of Docetaxel in Mesenchymal Triple Negative Breast Cancer Cells.
Journal: BioFactors (Oxford, England)
Published: February 20, 2025
Discovery of Anticancer Indole-Based 4,5-Dihydroisoxazole Derivative with Selectivity toward Leukemia Cells.
Journal: ACS pharmacology & translational science
Published: February 06, 2025
Pd2Spermine as an Alternative Therapeutics for Cisplatin-Resistant Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: April 09, 2024
Targeting hematological malignancies with isoxazole derivatives.
Journal: Drug discovery today
Published: February 20, 2024
Disclosing a metabolic signature of cisplatin resistance in MDA-MB-231 triple-negative breast cancer cells by NMR metabolomics.
Journal: Cancer cell international
Published: August 29, 2023
Pd(II) and Pt(II) Trinuclear Chelates with Spermidine: Selective Anticancer Activity towards TNBC-Sensitive and -Resistant to Cisplatin.
Journal: Pharmaceutics
Published: February 28, 2023
Effect of Pd2Spermine on Mice Brain-Liver Axis Metabolism Assessed by NMR Metabolomics.
Journal: International journal of molecular sciences
Published: October 21, 2022
Unravelling Potential Health-Beneficial Properties of Corema album Phenolic Compounds: A Systematic Review.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: September 07, 2022
Corema album Leaves Mediate DNA Damage in Triple-Negative Breast Cancer Cells.
Journal: Current issues in molecular biology
Published: June 17, 2022
Metabolic Impact of Anticancer Drugs Pd2Spermine and Cisplatin on the Brain of Healthy Mice.
Journal: Pharmaceutics
Published: December 20, 2021
Last Updated: 09/26/2026